|
Volumn 95, Issue 19, 2015, Pages 1471-1474
|
Clinical efficacy and safety of ulinastatin plus octreotide for patients with severe acute pancreatitis
|
Author keywords
Octreotide; Pancreatitis; Ulinastatin
|
Indexed keywords
AMYLASE;
C REACTIVE PROTEIN;
INTERLEUKIN 6;
OCTREOTIDE;
ULINASTATIN;
DRUG COMBINATION;
GLYCOPROTEIN;
IL6 PROTEIN, HUMAN;
ACUTE KIDNEY FAILURE;
ACUTE PANCREATITIS;
AMYLASE BLOOD LEVEL;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
LENGTH OF STAY;
LEUKOCYTE COUNT;
MAJOR CLINICAL STUDY;
MORTALITY;
RESPIRATORY DISTRESS;
SEVERE ACUTE PANCREATITIS;
SHOCK;
ADULT RESPIRATORY DISTRESS SYNDROME;
DRUG COMBINATION;
PANCREATITIS;
TREATMENT OUTCOME;
C-REACTIVE PROTEIN;
DRUG COMBINATIONS;
GLYCOPROTEINS;
HUMANS;
INTERLEUKIN-6;
OCTREOTIDE;
PANCREATITIS;
RESPIRATORY DISTRESS SYNDROME, ADULT;
TREATMENT OUTCOME;
|
EID: 84940521459
PISSN: 03762491
EISSN: None
Source Type: Journal
DOI: 10.3760/cma.j.issn.0376-2491.2015.19.008 Document Type: Article |
Times cited : (13)
|
References (7)
|